CorneaGen
PrivateLast Round
Series B
Oct 7, 2019
Total Funding Raised
$47M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CorneaGen is a medical device and biotechnology company that provides corneal transplant tissue, surgical instruments, and innovative therapeutic solutions to improve outcomes for patients with ocular diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CorneaGen Comparables
Compare CorneaGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brightstar Therapeutics | 80% | |
| Eversight | 76% | |
| KeraNatural | 76% |
CorneaGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 7, 2019 | ||||
| Series A | Oct 18, 2016 |
Key People
Founding team and executive leadership
CorneaGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Petrichor Healthcare Capital Management | Series B |
| Flying L Partners | Series A, Series B |
| Falcon Vision | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 33% MoM, reaching 6.3K.
- Oct 7, 2019
$37M round led by Petrichor Healthcare Capital Management and Flying L Partners.
CorneaGen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CorneaGen's valuation, stock price, and market status.
Is CorneaGen a public or private company?
CorneaGen is a private company.
What is the current stock price of CorneaGen?
CorneaGen is a private company with no public stock price. No recent secondary market data is available.
How much is CorneaGen worth (valuation)?
Valuation information for CorneaGen is not publicly available.
Can I buy CorneaGen stock?
CorneaGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CorneaGen's last funding round?
CorneaGen's most recent funding round was Series B on October 7, 2019.
Who are the main investors in CorneaGen?
Key investors in CorneaGen include Petrichor Healthcare Capital Management, Flying L Partners.
Will CorneaGen IPO soon?
No public IPO plans have been announced for CorneaGen.
How can I track CorneaGen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CorneaGen's secondary market activity and sign up for updates.